Lewis H. Titterton jr - Jun 1, 2021 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
Director
Signature
/s/ Lewis H. Titterton, Jr.
Stock symbol
ANIX
Transactions as of
Jun 1, 2021
Transactions value $
$0
Form type
4
Date filed
6/2/2021, 05:00 PM
Next filing
Jul 15, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option (Right to Buy) Award $0 +30K $0.00 30K Jun 1, 2021 Common Stock 30K $4.02 Direct F1, F2
transaction ANIX Employee Stock Option (Right to Buy) Award $0 +200K $0.00 200K Jun 1, 2021 Common Stock 200K $4.02 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
F2 The options vest and become exercisable in twelve (12) equal monthly installments beginning June 30, 2021.
F3 The options vest and become exercisable in thirty-six (36) equal monthly installments beginning June 30, 2021.